Skip to main content

Table 3 The correlation of LINC00221 expression with the progression of HCC

From: LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11

Clinicopathological characteristics Case LINC00221 expression p
Age (years)    0.689
 ≤ 45 16 3.076 ± 0.714  
 > 45 29 3.148 ± 0.512  
Gender    0.824
 Male 26 3.139 ± 0.540  
 Female 19 3.099 ± 0.654  
Tumor size    0.443
 ≤ 5 cm 17 3.035 ± 0.631  
 > 5 cm 28 3.175 ± 0.560  
Tumor number    0.282
 Single 30 3.055 ± 0.522  
 Multiple 15 3.256 ± 0.693  
Clinical grade    0.001
 I/II 21 2.822 ± 0.704  
 III 24 3.385 ± 0.262  
TNM stage    0.005
 I/II 28 2.936 ± 0.639  
 III 17 3.429 ± 0.300  
LNM    0.001
 Yes 11 3.517 ± 0.593  
 No 34 2.994 ± 0.336  
AFP (ng/mL)     < 0.001
 ≤ 200 21 2.824 ± 0.706  
 > 200 24 3.383 ± 0.262  
  1. HCC hepatocellular carcinoma, TNM tumor node metastasis, LNM lymph node metastasis, AFP alpha-fetoprotein